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AbstrACt
Objective To examine the change in both the prevalence 
and severity of metabolic syndrome (MetS) in the Sami 
and non-Sami in Northern Norway due to a lack of 
knowledge regarding the development of MetS in this 
population.
Design Repeated cross-sectional study.
setting The study is based on data from the SAMINOR 
1 Survey (2003–2004, n=6550) and the SAMINOR 2 
Clinical Survey (2012–2014, n=6004), conducted in 10 
municipalities in Northern Norway.
Participants Men and women aged 40–79 years were 
invited. We excluded participants not handing in the 
questionnaire and with missing information concerning 
ethnicity questions or MetS risk factors resulting in a final 
sample of 6308 (36.0% Sami) subjects in SAMINOR 1 and 
5866 (40.9% Sami) subjects in SAMINOR 2.
Outcome measures MetS prevalence was determined 
using the harmonised Adult Treatment Panel III (ATP-III) 
criteria, and severity was assessed with the MetS severity 
Z-score. Generalised estimating equations with an 
interaction term (survey × ethnicity) were used to compare 
prevalence and severity between the two surveys while 
accounting for partly repeated measurements.
results The overall, age-standardised ATP-III-MetS 
prevalence was 31.2% (95% CI: 29.8 to 32.6) in SAMINOR 
1 and 35.6% (95% CI: 34.0 to 37.3) in SAMINOR 2. Both 
the ATP-III-MetS prevalence and the mean MetS severity 
Z-score increased between the surveys in all subgroups, 
except the ATP-III-MetS prevalence in non-Sami women, 
which remained stable. Over time, Sami men showed a 
slightly larger increase in MetS severity than non-Sami 
men (p<0.001): the score increased by 0.20 (95% CI: 
0.14 to 0.25) and 0.06 (95% CI: 0.01 to 0.10) in Sami and 
non-Sami men, respectively. Abdominal obesity increased 
markedly between the surveys in all subgroups.
Conclusion The prevalence and severity of MetS 
increased over time in rural Northern Norway. Abdominal 
obesity appeared to drive the increase in ATP-III-MetS 
prevalence. Sami men had a slightly larger increase in 
severity than non-Sami.
IntrODuCtIOn
The co-occurrence of hypertension, abdom-
inal obesity, impaired fasting glucose, low 
high-density lipoprotein (HDL) cholesterol 
and increased triglyceride is known as meta-
bolic syndrome (MetS).1 MetS is viewed as 
a state of excess adiposity and insulin resis-
tance1 that increases the risk of cardiovas-
cular disease2 and type 2 diabetes mellitus 
(T2DM).3 The worldwide prevalence of 
obesity has doubled since 19804; however, 
excess visceral adiposity is associated with 
cardiometabolic abnormalities in both obese 
and non-obese individuals.5 Ethnic differences 
in body composition related to cardiometa-
bolic abnormalities further complicate this 
relationship.6 The dichotomous definition 
strengths and limitations of this study
 ► This study included data from two cross-sectional 
surveys with acceptable attendance rates and rela-
tively high proportions with Sami ethnicity.
 ► The change in metabolic syndrome  (MetS) over 
time was examined using generalised estimating 
equations, thus accounting for repeated measures 
and obtaining population averaged regression 
coefficients.
 ► Ethnic differences were detected in MetS risk with a 
continuous severity score that were not detectable 
with the dichotomous definition of MetS.
 ► A wide range of sensitivity analyses with respect to 
the diagnostic criteria and ethnic classification were 
conducted to ensure the internal validity of the study.
 ► The results cannot be generalised to the entire Sami 
and non-Sami population, and we were not able to 
include potential confounders such as physical ac-
tivity and diet.
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of MetS has been criticised for being a crude marker 
of risk that more likely operates on a continuous scale, 
and for the lack of consensus regarding the ethnic-spe-
cific cut-offs for abdominal obesity.7 Recently, Gurka et al 
constructed a sex- and ethnicity-specific continuous MetS 
severity Z-score8 that predicts coronary heart disease9 
and T2DM,10 independently of the individual MetS risk 
factors.
Northern Norway is inhabited by Norwegians, Sami 
and Kven. The Sami is an ethnic minority living in Sápmi, 
a settlement area covering northern parts of Norway, 
Sweden, Finland and Russia, and is regarded as indige-
nous people in Norway. The Sami culture has tradition-
ally centred around reindeer herding, farming, fishing 
and hunting, but nowadays few are left in these occupa-
tions. Internationally, indigenous and minority groups 
have elevated prevalences of chronic lifestyle diseases 
compared with majority populations,11 but little to no 
differences in the prevalences of cardiovascular disease 
and MetS (using the International Diabetes Federation 
definition) have been found in Sami and non-Sami in 
Norway.12–14 However, recent data have shown unfa-
vourable prevalences of obesity (women) and T2DM 
(women and men) among Sami when compared with 
non-Sami.15 16
We used the most up-to-date consensus definition 
of MetS, which is the harmonised Adult Treatment 
Panel-III (ATP-III) criteria,17 in addition to the MetS 
severity Z-score,8 to examine the prevalence and severity 
of MetS in Sami and non-Sami at two points in time and 
to examine whether variations in MetS prevalence and 
severity differed by ethnicity.
MethODs
We used data from two cross-sectional surveys of the 
Population-based Study on Health and Living Conditions 
in Regions with Sami and Norwegian Populations—The 
SAMINOR Study, which is run by the Centre for Sami 
Health Research (CSHR) at UiT The Arctic University of 
Norway. The first survey (SAMINOR 1) was carried out in 
collaboration with the National Institute of Public Health 
during 2003–2004 in 24 municipalities in Northern 
and Central Norway.18 The SAMINOR 2 Clinical Survey 
(SAMINOR 2) was carried out during 2012–2014 in 10 
of the municipalities included in SAMINOR 1.19 The 
present analyses are restricted to these 10 municipalities.
In both surveys, all inhabitants from these 10 munici-
palities who (1) were registered in the National Registry 
and (2) aged 40–79 years were invited to participate. Of 
all the inhabitants invited in SAMINOR 1 (n=11 518) and 
SAMINOR 2 (n=12 455), 6550 (56.9%) and 6004 (48.0%) 
individuals, respectively, attended the clinical examina-
tion and signed an informed consent (3872 participated 
in both surveys). The SAMINOR Project Board and The 
Regional Committee for Medical and Health Research 
Ethics approved this study.
Patient and public involvement
During the planning of the SAMINOR Study, CSHR 
consulted with the Sami Parliament. In addition, 
researchers/health workers who are either Sami or work 
in Sami core areas were consulted in order to meet the 
needs of the Sami community. In the case of abnormal 
findings during the examination, participants were 
encouraged to visit their primary physician. We intend to 
report the results of this study to decision makers, regional 
health establishments and authorities. An important aim 
of CSHR has always been to give the knowledge back 
to the participants of the study, often through popular 
science forums, meetings and lectures.
self-administered questionnaire
In both surveys, information on the duration of educa-
tion (years), use of blood pressure (BP) medication 
(currently/previously, but not now/never), DM (yes/
no), alcohol consumption, physical activity and diet was 
taken from a self-administered questionnaire. The ques-
tions on DM were not identical (SAMINOR 1: Do you 
have or have you had diabetes? SAMINOR 2: Have you ever 
been diagnosed with diabetes (elevated blood sugar levels)?). 
We did not include information on self-reported alcohol 
consumption, physical activity or diet in the analyses, as 
these questions were not similar enough for comparison.
Information on ethnic background cannot be recorded 
in Norwegian registries or medical records, but it can be 
solicited for research purposes. Three main aspects of 
ethnicity—language, ethnic background and self-per-
ceived ethnicity—were explored in the questionnaire 
through a total of 11 questions: What language do/did you/
your mother/your father/[all 4 of] your grandparents speak at 
home?; What is your/your father’s/your mother’s ethnic back-
ground?; What do you regard yourself as? Response options 
were: Norwegian, Sami, Kven or other, and participants 
could choose more than one answer. In order to be cate-
gorised as Sami, participants had to respond that (1) 
their own ethnic background or self-perceived ethnicity 
was Sami, and (2) the home language for at least one of 
their grandparents, parents or themselves was Sami. All 
participants who did not meet these criteria were catego-
rised as non-Sami.
Clinical examination
Trained personnel performed all clinical measurements 
and blood sampling using similar procedures in both 
surveys. BP was taken with a Dinamap-R automatic device 
(Criticon, Tampa, Florida, USA) in SAMINOR 1 and a 
CARESCAPE V100 monitor (GE Healthcare, Milwaukee, 
Wisconsin, USA) in SAMINOR 2, following at least 2 min 
of seated rest, with participants’ arms resting on a table. 
Three BP measurements were recorded at 1 min inter-
vals; the average of the second and third measurements 
was used in the analyses. Waist circumference (WC) was 
recorded to the nearest centimetre at the umbilicus, 
with the participant standing and breathing normally. 
Non-fasting blood samples were drawn by venipuncture, 
 on 6 A









pen: first published as 10.1136/bm




3Michalsen VL, et al. BMJ Open 2019;9:e027791. doi:10.1136/bmjopen-2018-027791
Open access
with participants in a seated position. In SAMINOR 1, 
serum was sent by mail and analysed consecutively at the 
Ullevål University Hospital, Oslo. In SAMINOR 2, serum 
was frozen on site at −20°C and sent to the biobank in 
Tromsø, where it was stored at −70°C and later analysed at 
the University Hospital of North Norway, Tromsø. Lipids 
and glucose were measured by an enzymatic method 
(Hitachi 917 autoanalyzer, Roche Diagnostic, Switzer-
land) in SAMINOR 1, and with a homogeneous enzy-
matic colorimetric method (Roche/Hitachi Cobas 8000B 
system, Roche Diagnostics GmbH, Mannheim, Germany) 
in SAMINOR 2.
Criteria for Mets
MetS was defined using the harmonised ATP-III criteria, 
which state that a combination of any three of the following 
five risk factors qualifies for a diagnosis of MetS17:
1. Hypertension: systolic BP ≥130 mm Hg, diastolic BP 
≥85 mm Hg or current use of BP medication.
2. Abdominal obesity: WC ≥80 cm in women and ≥94 cm 
in men, as recommended for a European population.5
3. Elevated non-fasting serum glucose ≥7.8 mmol/L. We 
chose this cut-off as it is a proxy for pre-diabetes de-
fined by an oral glucose tolerance test.20 Participants 
with self-reported DM were also considered to have el-
evated glucose.
4. Reduced non-fasting serum HDL cholester-
ol: <1.3 mmol/L in women and <1.0 mmol/L in men.
5. Elevated non-fasting serum triglycerides ≥1.7 mmol/L.
Common approaches when estimating the severity of 
MetS include to simply count the number of risk factors 
(0–5) with levels above the cut-offs or to sum up Z-scores 
of the five risk factors. However, these methods do not 
take into account the need for different weighting of 
risk factors in discrete ethnic groups and the two sexes. 
Nor have these methods been validated regarding future 
disease occurrence. Therefore, we chose to estimate 
the severity of MetS based on an ethnicity and sex-spe-
cific, continuous Z-score (https:// metscalc. org/) devel-
oped by Gurka et al in 2014. This score was constructed 
through confirmatory factor analyses to determine the 
weighted contribution of the five MetS risk factors to a 
latent MetS factor, with data from the NHANES survey 
on US adults aged 20–65 years.8 The score correlates 
with high levels of high-sensitivity C reactive protein, 
uric acid and insulin resistance,8 and predicts coronary 
heart disease9 and T2DM10 independent of its individual 
components. It operates like a Z-score, with mean 0 and 
SD 1, meaning that a score above/below 0 indicates a 
higher/lower severity of MetS than the average US adult 
aged 20–65 years. The score has been useful when applied 
in populations outside the USA as well.21–23 No cut-offs 
are available for the score, but this is less important in 
our study as our intention was to compare figures in 
the two ethnic groups. We used the sex-specific formula 
for non-Hispanic-whites for both Sami and non-Sami,8 
assuming similar weighting of risk factors.
Final study sample
Of the 6550 and 6004 individuals who participated in 
SAMINOR 1 and SAMINOR 2, we excluded those who 
did not fill in the questionnaire (SAMINOR 1 n=175/
SAMINOR 2 n=21); those with missing information on 
all ethnicity questions (n=27/n=75); and those with 
missing information on one or several MetS risk factors 
(systolic and diastolic BP, WC, glucose, HDL cholesterol 
and triglycerides, n=40/n=42). Thus, the final analyses 
included 6308 and 5866 participants, respectively. Some 
of these participants had missing information on educa-
tion (SAMINOR 1 n=419/SAMINOR 2 n=240), use of BP 
medication (n=105/n=221) and DM (n=351/n=138).
statistical analyses
All analyses were stratified by sex. Sample characteristics 
are presented for Sami and non-Sami participants in the 
two surveys; continuous variables are given as mean (SD) 
or median (IQR) where appropriate; categorical variables 
are given as numbers (percentage). In order to allow for 
comparison with international data, the overall preva-
lence for each survey was age-standardised by the direct 
method, using a European standard population from 
2013. We compared values in the two surveys for ATP-III-
MetS prevalence, MetS severity Z-score and all five MetS 
risk factors (seven outcomes in total) with generalised esti-
mating equation regression models with an exchangeable 
working correlation matrix.24 This method gives popula-
tion averaged regression coefficients while accounting 
for dependencies between repeated measures, as 3110 
individuals participated twice (25.5% overlapping obser-
vations). The MetS severity Z-score was log-transformed 
in models with a skewed distribution of the model resid-
uals. In order to make all values positive, we added 2.5, 
and then transformed these using the natural logarithm. 
Mean Z-scores were transformed back for presentation 
in tables. First, in order to compare values in the two 
surveys among Sami and non-Sami participants sepa-
rately, the models were stratified by ethnicity and run with 
age and survey as covariates. We calculated the age-ad-
justed prevalence or mean of all seven outcomes using 
the ‘marginal’ command in STATA, holding age constant 
at the sex-specific mean age in both surveys together 
(57.49 years for women, 58.15 years for men). Second, we 
tested whether variations in ATP-III-MetS prevalence and 
MetS severity Z-score differed by ethnicity, by using inter-
action terms (ethnicity x survey) in models that were not 
stratified by ethnicity. The interaction term was excluded 
from a model if p≥0.05. All statistical tests had a two-sided 
significance level of 0.05.
sensitivity analyses
In order to avoid spurious conclusions, we performed 
a wide range of sensitivity analyses, as recommended in 
ethnic health research.25 We repeated the analyses with
1. Alternative cut-offs for ATP-III-MetS risk factors: (1) 
WC ≥88 cm in women and ≥102 cm in men; (2) exclud-
ing WC, so those having ≥3 of 4 remaining risk factors 
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qualified as ATP-III-MetS; (3) glucose ≥11.1 mmol/L; 
(4) triglycerides ≥2.1 mmol/L.26
2. A ‘healthier’ sample, excluding participants that cur-
rently used BP or DM medication (tablets or insulin), 
or if they reported ever having had a myocardial infarc-
tion, angina pectoris or DM.
3. Two alternative measures of ethnicity: (1) answered 
‘Sami’ on all 11 questions, answered ‘Sami’ on 1–10 
questions, did not answer ‘Sami’ on any question; (2) 
solely based on self-perceived ethnicity.
4. Stratification by geographical regions (Inland Finnma-
rk County, coastal Finnmark County and Troms/Nor-
dland County).
5. Adjustment for education.
We used STATA V.15.1 for all statistical analyses. 
Graphics were created using the ‘ggplot2’ package for 
the open-source statistical software R V.3.4.2 (The R 
Foundation for Statistical Computing, URL https://www. 
R- project. org/).
results
The proportion of Sami in SAMINOR 1 and SAMINOR 
2 was 36.0% and 40.9%, respectively. On average, the 
SAMINOR 2 participants were older than the SAMINOR 
1 participants, had a longer education, higher prevalence 
of self-reported DM and larger WC (table 1).
The overall, age-standardised prevalence of MetS was 
31.2% (95% confidence interval [CI]: 29.8 to 32.6) 
in SAMINOR 1 and 35.6% (95% CI: 34.0 to 37.3) in 
SAMINOR 2 (data not shown).
The age-adjusted proportion of hypertension decreased 
modestly from SAMINOR 1 to SAMINOR 2, whereas the 
proportion of abdominal obesity increased markedly in all 
four strata of sex and ethnicity (between +15.3 percentage 
points (pp) and +26.4 pp). The proportion of elevated 
triglycerides increased markedly among both Sami 
women (+4.2 pp) and men (+9.1 pp). Both ATP-III-
MetS prevalence and MetS severity Z-score increased in 
all strata of sex and ethnicity, except for ATP-III-MetS 
Table 1 Sample characteristics stratified by sex, ethnicity and survey, given in mean (SD) or n (%)
Women
Sami participants Non-Sami participants
SAMINOR 1 SAMINOR 2 SAMINOR 1 SAMINOR 2
n=1150 n=1283 n=2176 n=1899
Age (years) 55.5 (10.2) 58.5 (10.4) 56.5 (10.1) 59.1 (10.7)
Education (years) 10.8 (4.7) 12.5 (4.4) 10.9 (3.8) 12.3 (4.0)
Waist circumference (cm) 86.5 (12.0) 93.6 (12.1) 85.6 (12.0) 92.9 (12.0)
Systolic BP (mm Hg) 130.6 (21.6) 130.0 (19.3) 133.0 (20.1) 131.1 (18.6)
Diastolic BP (mm Hg) 72.7 (10.3) 71.7 (9.2) 73.0 (10.5) 72.3 (9.0)
Triglycerides (mmol/L)* 1.36 (0.98) 1.40 (0.90) 1.35 (0.92) 1.40 (0.90)
Glucose (mmol/L)* 5.29 (1.07) 5.30 (1.10) 5.29 (1.09) 5.20 (1.00)
HDL cholesterol (mmol/L) 1.45 (0.37) 1.45 (0.41) 1.49 (0.40) 1.55 (0.45)
Self-reported diabetes mellitus 53 (4.8) 104 (8.3) 113 (5.6) 156 (8.5)
Current use of BP medication 270 (23.8) 352 (28.5) 556 (26.0) 550 (30.0)
Men n=1118 n=1113 n=1864 n=1571
Age (years) 56.3 (10.1) 59.8 (10.3) 56.4 (9.8) 60.3 (10.2)
Education (years) 10.3 (4.1) 11.4 (3.8) 10.9 (3.7) 11.8 (3.6)
Waist circumference (cm) 92.5 (10.6) 98.6 (10.6) 93.9 (10.2) 100.2 (10.7)
Systolic BP (mm Hg) 135.4 (20.0) 134.6 (18.0) 136.1 (17.6) 135.1 (17.2)
Diastolic BP (mm Hg) 78.3 (10.0) 77.0 (9.9) 78.2 (10.0) 77.8 (9.4)
Triglycerides (mmol/L)* 1.55 (1.27) 1.70 (1.20) 1.58 (1.14) 1.50 (1.10)
Glucose (mmol/L)* 5.42 (1.02) 5.40 (1.10) 5.41 (1.15) 5.40 (1.10)
HDL cholesterol (mmol/L) 1.27 (0.36) 1.23 (0.38) 1.28 (0.34) 1.28 (0.38)
Self-reported diabetes mellitus 48 (4.5) 107 (9.8) 75 (4.3) 146 (9.4)
Current use of BP medication 236 (21.5) 308 (29.0) 408 (22.3) 483 (31.9)
The SAMINOR 1 Survey (2003–2004, n = 6308) and the SAMINOR 2 Clinical Survey (2012–2014, n = 5866). 
All blood samples are non-fasting. Continuous variables are given as mean (SD) unless otherwise indicated. Categorical variables are given 
as n (%). For some variables, the total adds up to a lower number due to missing data. The maximum number missing (n=419) was for 
‘education’ in SAMINOR 1.
*Median (IQR) due to right-skewed data.
BP, blood pressure; HDL, high-density lipoprotein.
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in non-Sami women, which remained unchanged. In 
absolute numbers, ATP-III-MetS prevalence increased 
the most among Sami and non-Sami men (+8.2 pp 
and +7.5 pp, respectively, p<0.001 for both), whereas MetS 
severity Z-score increased the most among Sami women 
and Sami men (+0.13 and +0.21, respectively, p<0.001 for 
both) (table 2).
In the models assessing whether variations in ATP-III-
MetS prevalence and MetS severity Z-score between 
the surveys differed by ethnicity, interactions between 
ethnicity and survey were found for MetS severity, with 
Sami men having a larger increase than non-Sami men 
(p<0.001) (table 3). From the first to the second survey, 
the score increased by 0.20 (95% CI: 0.14 to 0.25) in Sami 
men and 0.06 (95% CI: 0.01 to 0.10) in non-Sami men 
(data not shown). In women, the interaction term between 
ethnicity and survey was also significant (p=0.024), but 
the difference in effect size was negligible (table 3).
Abdominal obesity increased across all age groups in all 
strata of sex and ethnicity between the surveys (figure 1). 
The MetS severity Z-score increased more in Sami men 
than in non-Sami men (figure 2).
Overall, sensitivity analyses, including alternative 
ethnic classifications, region and education, did not 
change the conclusions (data not shown). Results in 
Sami women were sensitive to alterations in cut-offs for 
ATP-III-MetS risk factors. Excluding abdominal obesity 
from the ATP-III-MetS criteria left only Sami men with a 
minor increase in prevalence (+3.5 pp, p=0.014) (see the 
online supplementary table 1). The interaction between 
ethnicity and survey for MetS severity was confirmed in 
the ‘healthier’ sample (in women and men) and using 
alternative ethnicity classifications (only in men) (data 
not shown).
DIsCussIOn
From 2003–2004 to 2012–2014, we observed an increase 
in both the prevalence (based on ATP-III criteria) and the 
severity of MetS in rural Northern Norway. The increases 
in prevalence were largest in men and were confirmed by 
sensitivity analyses. Non-Sami women had stable measures 
of MetS prevalence, but a small increase in MetS severity. 
Sami of both sexes had a slightly larger increase in MetS 
severity than non-Sami; this finding was most pronounced 
and most robust in men. Abdominal obesity increased 
markedly in all strata of sex and ethnicity.
strengths and limitations
The relatively large sample size (n=6308 and n=5866) is 
a strength of our study, and we had an acceptable atten-
dance rate (54.8% and 47.1%). In general, non-atten-
dance was high among men aged 40–49 years. We could 
not evaluate ethnicity-specific non-attendance rates, as 
national registers do not record ethnicity. Due to design 
issues and varying response rates across municipalities, 
the SAMINOR 1 sample includes a lower proportion of 
people from Sami majority areas in Finnmark County 
and a higher proportion from Northern Troms County as 
compared with the SAMINOR 2 sample. These different 
geographic and ethnic compositions challenge our ability 
to compare the samples, nor can we generalise the results 
of this study to the entire Sami and non-Sami population. 
Analyses of participants excluded due to missing data 
(n=242 in SAMINOR 1, n=138 in SAMINOR 2) revealed 
that they were older, had lower education and had a slightly 
worse cardiometabolic profile; we could not determine if 
this varied by ethnic belonging. An important weakness 
in our study is that blood samples were non-fasting, as the 
time schedule was distributed during the entire day. Lipid 
levels vary little according to fasting state, except mean 
triglycerides levels, which have been found to vary around 
20% between different fasting states.24 A more important 
issue is that using non-fasting glucose as a diagnostic tool 
is not valid regarding neither pre-diabetes nor diabetes. 
HbA1c was available in SAMINOR 2 only, such that in 
order for us to make comparisons between the surveys, 
we had to choose non-fasting glucose. Other weaknesses 
included self-reported DM status and drug use and the 
lack of socioeconomic factors other than education. 
However, the internal validity of this study is high. We 
performed a wide range of sensitivity analyses with alter-
ations in cut-offs for MetS risk factors, restricted samples 
and ethnic classification. We assumed that the prevalence 
and severity of MetS could be defined in the same way in 
Sami and non-Sami, thus, our results would be invalid if 
these assumptions were revealed to be incorrect. Despite 
the limitations, we believe that we have added novel infor-
mation on cardiometabolic health by utilising a MetS 
severity Z-score.
Comparison with other studies
The overall ATP-III-MetS prevalences we report in this 
study from rural Northern Norway were much higher 
than that reported in the sixth survey of the Tromsø 
Study (2007–2008, 22.6%), which sampled from an urban 
area in Northern Norway.27 Thus, regional differences in 
MetS may be larger than ethnic differences in MetS in 
rural areas. Consequently, public health efforts to reduce 
the burden of MetS risk factors should focus more on 
the region than on ethnicity. The ATP-III-MetS preva-
lences we found were also higher than those reported in 
other Arctic populations, such as the Greenland Inuit,28 
the Yup’ik Eskimo29 and indigenous Nenets women in 
Russia.30 However, valid comparisons of MetS prevalences 
are challenging due to differences in study years, age 
distributions, MetS criteria and fasting versus non-fasting 
blood samples. Decreases in hypertension and increases 
in abdominal obesity have been reported both nation-
ally and internationally.31–33 Abdominal obesity, which 
appeared to be the driving force behind the increased 
ATP-III-MetS prevalences in our study, was present in 
nearly 90% of women and in more than two-thirds of 
men in 2012–2014. The cut-offs for waist circumference 
that we used are quite strict, such that we found a large 
proportion with abdominal obesity with only one or no 
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additional MetS risk factors. Nevertheless, general obesity 
(body mass index ≥30 kg/m2), without MetS, is known 
as metabolically healthy obesity and has been reported 
to confer significant risk of cardiovascular disease and 
T2DM in long-term follow-up studies.34 35 As research has 
indicated that metabolically healthy obesity is an unstable 
condition,36 efforts should be made to prevent weight 
gain and promote weight loss in all obese individuals, 
regardless of MetS presence.
Possible implications of ethnic differences
The ethnic differences in the change of MetS severity 
from 2003–2004 to 2012–2014, were more robust in men 
than in women. The MetS severity increased by 0.20 (95% 
CI: 0.14 to 0.25) in Sami men and 0.06 (95% CI: 0.01 to 
0.10) in non-Sami men, which is a modest difference. 
However, in a longitudinal study it was shown that irre-
spective of baseline MetS severity Z-scores, individuals 
with a change of ≥0.5 in this score had an increased risk 
of T2DM compared with those with a change of ≤0.10 
Moreover, in a cohort study that followed nearly 300 000 
individuals for 25 years, subtle elevations in metabolic risk 
factors (obesity, glucose and triglycerides) were observed 
decades before T2DM onset.37 Thus, even minor differ-
ences may be indicative of future differences in DM. As 
the differences between Sami and non-Sami men are 
small in our study, we are reluctant to speculate in detail 
what the implications of the results are. But, a few previous 
findings are interesting in the light of our results. In 
1974–1975, Sami in Finnmark County had a reduced risk 
of T2DM compared with non-Sami.14 However, in 2012–
2014, a study from Northern Norway, including parts of 
Finnmark, Troms and Nordland counties, reported that 
Sami had a higher prevalence of self-reported T2DM than 
non-Sami; this was evident in both sexes.16 Conversely, no 
ethnic differences in the 10-year risk of non-fatal cardio-
vascular disease or self-reported myocardial infarction was 
found in rural Northern Norway.12 38 In fact, both ATP-III-
MetS and MetS severity Z-score have stronger associations 
with T2DM than with coronary heart disease.2 3 9 10 The 
MetS severity Z-score has the highest factor loadings 
for HDL cholesterol and triglycerides,8 which probably 
explains why this score increased more among Sami, 
as there was ethnic heterogeneity in the distribution of 
these two MetS risk factors. In sum, available research 
may indicate a more detrimental metabolic development 
associated with T2DM in Sami than in non-Sami men.
Possible explanations for ethnic differences
Prior to a discussion on possible explanations for the 
ethnic differences, we emphasise that they are quite 
small. In an international perspective, it is not common 
to observe such small differences between an indigenous 
population and the majority reference population. We 
Table 3 Sex-stratified GEE models examining potential interactions between survey and ethnicity for ATP-III MetS and MetS 
severity Z-score
ATP-III MetS MetS severity Z-score
OR (95% CI) P value β (95% CI) P value
Women
  Survey
  SAMINOR 2 vs SAMINOR 1 1.08 (0.99 to 1.18) 0.095 0.02 (0.01 to 0.04) 0.010
  Ethnicity
  Sami vs non-Sami 1.16 (1.03 to 1.30) 0.011 0.02 (−0.01 to 0.04) 0.14
  Survey × ethnicity
  SAMINOR 2 × Sami — 0.03 (0.00 to 0.05) 0.024
  Age (per 10 years) 1.37 (1.30 to 1.45) <0.001 0.09 (0.08 to 0.10) <0.001
Men
  Survey
  SAMINOR 2 vs SAMINOR 1 1.43 (1.29 to 1.58) <0.001 0.06 (0.01 to 0.10) 0.021
  Ethnicity
  Sami vs non-Sami 1.00 (0.89 to 1.13) 0.95 −0.02 (−0.07 to 0.04) 0.62
  Survey × ethnicity
  SAMINOR 2 × Sami — 0.14 (0.07 to 0.21) <0.001
  Age (per 10 years) 1.06 (1.00 to 1.12) 0.034 −0.04 (−0.06 to 0.02) 0.001
We tested whether the change in ATP-III MetS and MetS severity Z-score differed by ethnicity, by using interaction terms (ethnicity × survey) 
in GEE logistic or linear models that included age, survey and ethnicity as covariates. Analyses were not stratified by ethnicity. The interaction 
term was excluded from a model if p≥0.05. In women, the MetS severity Z-score was log-transformed. When interpreting the coefficients for 
survey and ethnicity in the models for MetS severity Z-score, one should be aware that these must be interpreted together with the interaction 
term.
ATP-III, Adult Treatment Panel III; GEE, generalised estimating equation; MetS, metabolic syndrome.
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Figure 1 Proportion with values above the cut-off for each cardiometabolic risk factor comprising metabolic syndrome 
(A–J), per 10-year age group, with vertical error bars (95% CI). P values for the survey are age-adjusted and were obtained 
with GEE logistic regression. Models were stratified by sex and ethnic group. (A and B) Hypertension defined as systolic 
blood pressure ≥130 mm Hg, diastolic blood pressure ≥85 mm Hg or current use of blood pressure medication. (C and 
D) Abdominal obesity defined as waist circumference ≥80 cm in women and ≥94 cm in men. (E and F) Elevated glucose 
defined as glucose ≥7.8 mmol/L or self-reported diabetes mellitus. (G and H) Reduced HDL cholesterol defined as HDL 
cholesterol <1.3 mmol/L in women and <1.0 mmol/L in men. (I and J) Elevated triglycerides defined as triglycerides ≥1.7 mmol/L. 
GEE, generalised estimating equation; HDL, high-density lipoprotein. 
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speculate that our positive findings may be explained by 
the fact that the Sami and non-Sami mostly live side-by-side 
in the same geographical areas. Thus, important social 
determinants of health, such as education, job oppor-
tunities and health services, should be equally available 
independent of ethnicity. We also reiterate that regional 
differences may be of a much larger magnitude than the 
ethnic differences27 and this calls for continued public 
health surveillance in rural Northern Norway. Further, 
in an effort to explain ethnic health differences, one 
should keep in mind that ethnicity comprises an inter-
play between lifestyle, geography, culture and possibly 
genetics. It is likely that lifestyle factors such as diet and 
physical activity—which are strongly associated with MetS 
development39—mediate, at least to some degree, the 
(weak) association between ethnicity and MetS. There 
are some studies on differences in physical activity and 
dietary habits in Sami and non-Sami,40–42 but they are 
both insufficient (ie, no information on the total level of 
physical activity) and cross-sectional. Unfortunately, we 
Figure 2 P values for survey are age-adjusted and were obtained with GEE logistic or linear regression. Models were stratified 
by sex and ethnic group. (A and B) Prevalence of MetS defined by the harmonised ATP-III criteria, per 10-year age group 
with vertical error bars (95% CI). (C and D) Mean of MetS severity Z-score as a function of age with 95% CI bands shaded in 
grey. ATP-III, Adult Treatment Panel III; GEE, generalised estimating equation; MetS, metabolic  syndrome. 
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were not able to include such variables in our analyses. 
A complex facet of ethnicity is represented by potential 
differences in body composition6; thus, if such a differ-
ence exists between Sami and non-Sami, it could have led 
us to misclassify some participants as obese. For instance, 
the Greenland Inuit have a more favourable cardiometa-
bolic profile and lower amounts of visceral adipose tissue 
at the same level of obesity as Danes.43 44 On average, Sami 
have a shorter stature than non-Sami, and when adjusting 
for waist-to-height-ratio, the differences in T2DM between 
Sami and non-Sami in SAMINOR 2 were eliminated.16 
Finally, we emphasise that there is heterogeneity in all 
aspects comprising ethnicity within the Sami population, 
just as there is heterogeneity between the Sami and the 
non-Sami. Our results suggest that further research on 
the ethnic differences in the adiposity-related MetS risk 
profile in rural Northern Norway is warranted.
COnClusIOn
We found a high burden of MetS in rural Northern 
Norway. From 2003–2004 to 2012–2014, both the prev-
alence (ATP-III-MetS) and the severity (Z-score) of MetS 
increased in the 10 selected municipalities. The largest 
increases in prevalence were observed in Sami and 
non-Sami men. In Sami men, the increase in MetS severity 
was slightly larger than in non-Sami. Abdominal obesity 
appeared to be the driving force behind the increase in 
ATP-III-MetS and should be a public health target regard-
less of ethnicity or MetS presence.
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